Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).

Haase R, Vilser C, Mauz-Körholz C, Hasenclever D, Kluge R, Ruschke K, Borkhardt A, Seeger K, Lehrnbecher T, Kulozik A, Rößler J, Burdach S, Jürgens H, Körholz D.

Klin Padiatr. 2012 Oct;224(6):377-81. doi: 10.1055/s-0032-1323824. Epub 2012 Oct 9.

PMID:
23047832
2.
3.

C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.

Wieland A, Kerbl R, Berghold A, Schwinger W, Mann G, Urban C.

Med Pediatr Oncol. 2003 Jul;41(1):21-5.

PMID:
12764738
4.

Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

Dörffel W, Lüders H, Rühl U, Albrecht M, Marciniak H, Parwaresch R, Pötter R, Schellong G, Schwarze EW, Wickmann L.

Klin Padiatr. 2003 May-Jun;215(3):139-45.

PMID:
12838937
6.

[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].

Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.

Ai Zheng. 2006 Aug;25(8):1013-8. Chinese.

PMID:
16965685
7.

The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma.

Vassilakopoulos TP, Nadali G, Angelopoulou MK, Siakantaris MP, Dimopoulou MN, Kontopidou FN, Karkantaris C, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Pizzolo G, Pangalis GA.

Haematologica. 2002 Jul;87(7):701-8; discussion 708.

8.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
9.

Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.

Henry-Amar M, Friedman S, Hayat M, Somers R, Meerwaldt JH, Carde P, Burgers JM, Thomas J, Monconduit M, Noordijk EM, et al.

Ann Intern Med. 1991 Mar 1;114(5):361-5.

PMID:
1992877
10.

Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB.

Glimelius I, Molin D, Amini RM, Gustavsson A, Glimelius B, Enblad G.

Eur J Haematol. 2003 Nov;71(5):327-33.

PMID:
14667195
11.

Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.

Visco C, Nadali G, Vassilakopoulos TP, Bonfante V, Viviani S, Gianni AM, Federico M, Luminari S, Peethambaram P, Witzig TE, Pangalis G, Cabanillas F, Medeiros LJ, Sarris AH, Pizzolo G.

Eur J Haematol. 2006 Nov;77(5):387-94. Epub 2006 Jul 27.

PMID:
16879607
12.

[Treatment results of Hodgkin's lymphoma].

Aleknavicius E, Valuckas KP, Aleknaviciene B, Norkiene L, Smailyte G.

Medicina (Kaunas). 2009;45(8):615-23. Lithuanian.

13.

[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].

Niu Y, Shi YK, He XH, Feng FY, Zhou LQ, Gu DZ.

Zhonghua Zhong Liu Za Zhi. 2008 Aug;30(8):630-4. Chinese.

PMID:
19102946
14.
15.

Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.

Akhtar S, El Weshi A, Abdelsalam M, Hussaini H, Janabi I, Rahal M, Maghfoor I.

Bone Marrow Transplant. 2007 Oct;40(7):651-8. Epub 2007 Jul 30.

PMID:
17660837
16.

Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study group.

Klimm B, Franklin J, Stein H, Eichenauer DA, Haverkamp H, Diehl V, Fuchs M, Borchmann P, Engert A.

J Clin Oncol. 2011 Oct 10;29(29):3914-20. doi: 10.1200/JCO.2011.36.4703. Epub 2011 Sep 12.

PMID:
21911729
17.

[Primary-refractory forms of Hodgkin's lymphoma].

Filatova LV, Tarasenkova AA, Gershanovich ML, Semiglazova TIu.

Vopr Onkol. 2012;58(5):627-38. Russian.

PMID:
23600279
18.

[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].

Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.

Ai Zheng. 2007 Dec;26(12):1360-4. Chinese.

PMID:
18076802
19.

[Influence of age on treatment results in children and adolescents with Hodgkin's disease].

Balwierz W, Moryl-Bujakowska A, Depowska T, Klekawka T, Stanuch H, Matysiak M, Sopyło B, Kołakowska-Mrozowska B, Krenke K, Chybicka A, Raś M, Sońta-Jakimczyk D, Moszant A, Wachowiak J, Kaczmarek-Kanold M, Kowalczyk J, Odój T, Balcerska A, Drozyńska E, Wysocki M, Kołtan A, Krawczuk-Rybak M, Stolarska M.

Przegl Lek. 2004;61 Suppl 2:40-4. Polish.

PMID:
15686044
20.

[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].

Mjaaland I, Ganser D, Freitag EM, Bohndorf W.

Strahlenther Onkol. 1994 Sep;170(9):516-23. German.

PMID:
7524173

Supplemental Content

Support Center